The Hypotensive Effects of Home-Based Isometric Handgrip Training in Older Adults With Pre-Hypertension and Hypertension - The HoldAge Trial

NCT04275037 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2023-05-22

No results posted yet for this study

Summary

New data suggests that isometric handgrip training (IHT) might become a novel tool in the treatment of hypertension. The main purpose of this research project is to evaluate the effects of home-based IHT on ambulatory blood pressure in older adults with pre-hypertension and hypertension. Eighty-four older adults with pre-hypertension and hypertension will be randomly distributed to one of three groups: home-based IHT, home-based aerobic exercise training (AET), or attention-control group (CON). Each intervention will have a total duration of 8 weeks. At baseline and after completing the intervention, patients will undergo the following evaluations: 24-hour ambulatory blood pressure, cardiorespiratory fitness, endothelial function, damage and repair, arterial stiffness, inflammatory biomarkers, autonomic function, physical activity levels, dietary intake and quality of life. A qualitative analysis will also be applied to enhance the understanding of the efficacy of this intervention from the patient's perspective.

Conditions

Interventions

OTHER

Isometric Handgrip Training

The 8-week exercise program will include three sessions of isometric handgrip training per week

OTHER

Aerobic Exercise Training

The 8-week exercise program will include three sessions of aerobic exercise per week

Sponsors & Collaborators

  • Aveiro University

    collaborator OTHER
  • Hospital Infante D. Pedro, Centro Hospitalar Do Baixo Vouga

    collaborator UNKNOWN
  • Hospital Pedro Hispano, ULS Matosinhos

    collaborator UNKNOWN
  • Porto University

    collaborator UNKNOWN
  • University of Connecticut

    collaborator OTHER
  • Unidade de Saúde Familiar de Santa Joana

    collaborator UNKNOWN
  • Research Center in Sports Sciences, Health Sciences and Human Development

    collaborator OTHER
  • Unidade de Saúde Familiar Serzedelo

    collaborator UNKNOWN
  • University Institute of Maia

    lead OTHER

Principal Investigators

  • Alberto J Alves, PhD · CIDESD, University Institute of Maia, Maia, Portugal

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-12
Primary Completion
2023-01-30
Completion
2023-01-30

Countries

  • United States
  • Portugal

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04275037 on ClinicalTrials.gov